Novel Role for SLPI in MOG-induced EAE Revealed by Spinal Cord Expression Analysis

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2008 May 27

PMID 18501024

Citations 25

Authors

Andre M Mueller

Xiomara Pedre

Thomas Stempfl

Ingo Kleiter

Sebastien Couillard-Despres

Ludwig Aigner

Gerhard Giegerich

Andreas Steinbrecher

Affiliations

Soon will be listed here.

Abstract

Background: Experimental autoimmune encephalomyelitis (EAE) induced by myelin oligodendrocyte protein (MOG) in female Dark Agouti (DA) rats is a chronic demyelinating animal model of multiple sclerosis (MS). To identify new candidate molecules involved in the evolution or repair of EAE-lesions we used Affymetrix oligonucleotide microarrays to compare the spinal cord transcriptome at the peak of EAE, during remission and at the first relapse with healthy DA rats.

Methods: Untreated DA rats and DA rats immunised with MOG protein were sacrificed at defined time points. Total RNA was isolated from spinal cord tissue and used for hybridization of Affymetrix rat genome arrays RG U34 A-C. Selected expression values were confirmed by RealTime PCR. Adult neural stem cells were incubated with recombinant secretory leukocyte protease inhibitor (SLPI). Proliferation was assessed by BrdU incorporation, cyclin D1 and HES1 expression by RealTime PCR, cell differentiation by immunofluorescence analysis and I kappa B alpha degradation by Western blot.

Results: Among approximately 26,000 transcripts studied more than 1,100 were differentially regulated. Focussing on functional themes, we noticed a sustained downregulation of most of the transcripts of the cholesterol biosynthesis pathway. Furthermore, we found new candidate genes possibly contributing to regenerative processes in the spinal cord. Twelve transcripts were solely upregulated in the recovery phase, including genes not previously associated with repair processes. Expression of SLPI was upregulated more than hundredfold during EAE attack. Using immunohistochemistry, SLPI was identified in macrophages, activated microglia, neuronal cells and astrocytes. Incubation of adult neural stem cells (NSC) with recombinant SLPI resulted in an increase of cell proliferation and of differentiation towards oligodendrocytes. These processes were paralleled by an upregulation of the cell-cycle promotor cyclin D1 and a suppression of the cell differentiation regulator HES1. Finally, SLPI prevented the degradation of I kappa B alpha, which may explain the suppression of the cell differentiation inhibitor HES1 suggesting a possible mechanism of oligodendroglial differentiation.

Conclusion: We identified novel features of gene expression in the CNS during EAE, in particular the suppression of genes of cholesterol biosynthesis and a strong upregulation of SLPI, a gene which is for the first time associated with autoimmune inflammation. The capacity of SLPI to increase proliferation of adult NSC and of oligodendroglial differentiation suggests a novel role for SLPI in the promotion of tissue repair, beyond its known functions in the prevention of tissue damages by protease inhibition damage and modulation of inflammatory reactions.

Citing Articles

Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet.

Montgomery T, Peipert D, Krementsov D Immunol Rev. 2024; 325(1):131-151.

PMID: 38717158 PMC: 11338732. DOI: 10.1111/imr.13343.

The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications.

Mongkolpathumrat P, Pikwong F, Phutiyothin C, Srisopar O, Chouyratchakarn W, Unnajak S Heliyon. 2024; 10(2):e24550.

PMID: 38312697 PMC: 10835312. DOI: 10.1016/j.heliyon.2024.e24550.

Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model.

das Neves S, Sousa J, Magalhaes R, Gao F, Coppola G, Meriaux S Cells. 2023; 12(20).

PMID: 37887329 PMC: 10605171. DOI: 10.3390/cells12202484.

Genome-Wide Expression Profile in People with Optic Neuritis Associated with Multiple Sclerosis.

Habek M, Blazekovic A, Jercic K, Pivac N, Outero T, Borovecki F Biomedicines. 2023; 11(8).

PMID: 37626706 PMC: 10452153. DOI: 10.3390/biomedicines11082209.

Immune stimulation recruits a subset of pro-regenerative macrophages to the retina that promotes axonal regrowth of injured neurons.

Andries L, Kancheva D, Masin L, Scheyltjens I, Van Hove H, De Vlaminck K Acta Neuropathol Commun. 2023; 11(1):85.

PMID: 37226256 PMC: 10210300. DOI: 10.1186/s40478-023-01580-3.

References

Matejuk A, Hopke C, Dwyer J, Subramanian S, Jones R, Bourdette D . CNS gene expression pattern associated with spontaneous experimental autoimmune encephalomyelitis. J Neurosci Res. 2003; 73(5):667-78. DOI: 10.1002/jnr.10689. View

Steinman L . Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron. 1999; 24(3):511-4. DOI: 10.1016/s0896-6273(00)81107-1. View

Sugimoto K, Honda S, Yamamoto T, Ueki T, Monden M, Kaji A . Molecular cloning and characterization of a newly identified member of the cadherin family, PB-cadherin. J Biol Chem. 1996; 271(19):11548-56. DOI: 10.1074/jbc.271.19.11548. View

Zhang D, Simmen R, Michel F, Zhao G, Vale-Cruz D, Simmen F . Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes. J Biol Chem. 2002; 277(33):29999-30009. DOI: 10.1074/jbc.M203503200. View

Marta C, Oliver A, Sweet R, Pfeiffer S, Ruddle N . Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci U S A. 2005; 102(39):13992-7. PMC: 1236555. DOI: 10.1073/pnas.0504979102. View

Ashcroft G, Lei K, Jin W, Longenecker G, Kulkarni A, Greenwell-Wild T . Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat Med. 2000; 6(10):1147-53. DOI: 10.1038/80489. View

Goselink H, Van Damme J, Hiemstra P, Wuyts A, Stolk J, Fibbe W . Colony growth of human hematopoietic progenitor cells in the absence of serum is supported by a proteinase inhibitor identified as antileukoproteinase. J Exp Med. 1996; 184(4):1305-12. PMC: 2192846. DOI: 10.1084/jem.184.4.1305. View

Zipp F, Waiczies S, Aktas O, Neuhaus O, Hemmer B, Schraven B . Impact of HMG-CoA reductase inhibition on brain pathology. Trends Pharmacol Sci. 2007; 28(7):342-9. DOI: 10.1016/j.tips.2007.05.001. View

Carmody R, Hilliard B, Maguschak K, Chodosh L, Chen Y . Genomic scale profiling of autoimmune inflammation in the central nervous system: the nervous response to inflammation. J Neuroimmunol. 2002; 133(1-2):95-107. DOI: 10.1016/s0165-5728(02)00366-1. View

10.

Schanzer A, Wachs F, Wilhelm D, Acker T, Cooper-Kuhn C, Beck H . Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol. 2004; 14(3):237-48. PMC: 8096047. DOI: 10.1111/j.1750-3639.2004.tb00060.x. View

11.

Pender M, Nguyen K, McCombe P, KERR J . Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci. 1991; 104(1):81-7. DOI: 10.1016/0022-510x(91)90219-w. View

12.

Deisseroth K, Singla S, Toda H, Monje M, Palmer T, Malenka R . Excitation-neurogenesis coupling in adult neural stem/progenitor cells. Neuron. 2004; 42(4):535-52. DOI: 10.1016/s0896-6273(04)00266-1. View

13.

Daily D, Vlamis-Gardikas A, Offen D, Mittelman L, Melamed E, Holmgren A . Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways. J Biol Chem. 2001; 276(24):21618-26. DOI: 10.1074/jbc.M101400200. View

14.

Zhou D, Srivastava R, Nessler S, Grummel V, Sommer N, Bruck W . Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci U S A. 2006; 103(50):19057-62. PMC: 1748176. DOI: 10.1073/pnas.0607242103. View

15.

Lentsch A, Yoshidome H, Warner R, Ward P, Edwards M . Secretory leukocyte protease inhibitor in mice regulates local and remote organ inflammatory injury induced by hepatic ischemia/reperfusion. Gastroenterology. 1999; 117(4):953-61. DOI: 10.1016/s0016-5085(99)70355-0. View

16.

Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H . Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002; 8(5):500-8. DOI: 10.1038/nm0502-500. View

17.

Wang X, Li X, Xu L, Zhan Y, Yaish-Ohad S, Erhardt J . Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury. Mol Pharmacol. 2003; 64(4):833-40. DOI: 10.1124/mol.64.4.833. View

18.

Marin-Husstege M, He Y, Li J, Kondo T, Sablitzky F, Casaccia-Bonnefil P . Multiple roles of Id4 in developmental myelination: predicted outcomes and unexpected findings. Glia. 2006; 54(4):285-96. DOI: 10.1002/glia.20385. View

19.

Bedford L, Walker R, Kondo T, van Cruchten I, King E, Sablitzky F . Id4 is required for the correct timing of neural differentiation. Dev Biol. 2005; 280(2):386-95. DOI: 10.1016/j.ydbio.2005.02.001. View

20.

Xu W, He B, Chiu A, Chadburn A, Shan M, Buldys M . Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat Immunol. 2007; 8(3):294-303. DOI: 10.1038/ni1434. View